SCHEMBL13412924

SCHEMBL13412924

O=C(C[C@H](NP)C(=O)O)OCc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.53
MAPK1 P28482 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
SLC15A1 P46059 2/20 0.50
MMP9 P14780 1/20 0.49
CASP1 P29466 3/20 0.45
SLC6A2 P23975 1/20 0.45
SLC6A3 Q01959 1/20 0.45
KMT2A Q03164 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
CDC25B P30305 1/20 0.44
ABCB1 P08183 1/20 0.43
LMNA P02545 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
PPARG P37231 1/20 0.41
PPARA Q07869 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24633781 0.88 ALDH1A1 (0.53) ALDH1A1MAPK1L3MBTL1SLC15A1MMP9
SCHEMBL9448685 0.88 SLC15A1 (0.53) ALDH1A1MAPK1L3MBTL1SLC15A1MMP9
SCHEMBL16446118 0.84 ALDH1A1 (0.53) ALDH1A1MAPK1L3MBTL1SLC15A1MMP9
SCHEMBL17995311 0.84 ALDH1A1 (0.53) ALDH1A1MAPK1L3MBTL1SLC15A1MMP9
SCHEMBL23901564 0.84 ALDH1A1 (0.53) ALDH1A1MAPK1L3MBTL1SLC15A1MMP9
SCHEMBL13936459 0.84 ALDH1A1 (0.53) ALDH1A1MAPK1L3MBTL1SLC15A1MMP9
SCHEMBL14655692 0.83 ALDH1A1 (0.51) ALDH1A1MAPK1L3MBTL1SLC15A1MMP9
SCHEMBL21555767 0.83 ALDH1A1 (0.51) ALDH1A1MAPK1L3MBTL1SLC15A1MMP9
SCHEMBL28777999 0.83 ALDH1A1 (0.51) ALDH1A1MAPK1L3MBTL1SLC15A1MMP9
SCHEMBL7583002 0.83 CASP1 (0.60) ALDH1A1CASP1PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7687492-B2 1,2,4-Oxadiazole derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes MERCK SHARP & DOHME CORP. (US) 2010-03-30 US disclosed
US-20080021009-A1 1,2,4-Oxadiazole Derivatives as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes MERCK SHARP & DOHME LLC 2008-01-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080021009-A1 1,2,4-Oxadiazole Derivatives as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes DPP4, DPP3, DPP7 ALDH1A1 378/4885MAPK1 3390/4885L3MBTL1 3742/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.